{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-23-000353","form_type":"8-K","ticker":null,"cik":"0001851657","company_name":"Vaxxinity, Inc.","filed_at":"2023-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.770666+00:00","generated_at":"2026-06-10T07:45:58.625985+00:00","sec_items":["4.01","5.02","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vaxxinity appoints FORVIS as new auditor; GC departs, new Chief Legal Officer named","bullets":["Audit committee appoints FORVIS, LLP as independent auditor effective Sept 27, 2023, replacing Armanino.","General Counsel René Paula resigns effective Nov 3, 2023 to pursue other opportunities.","Sumita Ray appointed Chief Legal & Administrative Officer effective Oct 1, 2023.","Ray brings 20+ years pharma/biotech experience, previously at Pharmacyclics, Calithera, Instil Bio.","Armanino had resigned citing transition away from public company audits; FORVIS to review Q3 2023 10-Q."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-23-000353","json":"https://secwatch.observer/filing/0001562762-23-000353.json","markdown":"https://secwatch.observer/filing/0001562762-23-000353.md","text":"https://secwatch.observer/filing/0001562762-23-000353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/0001562762-23-000353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/20230927_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:45:58.625985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f00ea4ef8414b02e5129467e2c42fdc4e23a1630","claim":"Vaxxinity, Inc. engaged FORVIS, LLP as its auditor.","evidence_excerpt":"On September 27, 2023, the Audit Committee of the Board of Directors of Vaxxinity, Inc. (the “Company”) appointed FORVIS, LLP (“FORVIS”) as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/0001562762-23-000353-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"FORVIS, LLP"}],"fact_type":"auditor_change"},{"claim_id":"6b701372f1","claim":"René Paula resigned as General Counsel at Vaxxinity, Inc..","evidence_excerpt":"René Paula notified the Company that he intends to resign from his position as the Company’s General Counsel, effective November 3, 2023, to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/0001562762-23-000353-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"General Counsel"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}